Vascular Mechanisms of PFAS Hypertension
PFAS induce endothelial dysfunction — impairment of the vascular lining cells that regulate blood vessel tone — through nitric oxide depletion and oxidative stress. Nitric oxide produced by endothelial cells causes vasodilation; PFAS-induced reduction in endothelial nitric oxide synthase (eNOS) activity reduces vasodilation capacity, promoting higher baseline vascular resistance and blood pressure.
PFAS also activate the renin-angiotensin-aldosterone system (RAAS) — the hormonal cascade that is the primary target of many antihypertensive medications. PFAS-mediated aldosterone excess promotes sodium retention and blood volume expansion, raising blood pressure through hemodynamic rather than vascular resistance mechanisms.
Human Studies on PFAS and Blood Pressure
Cross-sectional analyses in NHANES find positive associations between serum PFAS levels and systolic blood pressure, diastolic blood pressure, and hypertension diagnosis, with the strongest associations in middle-aged adults. A meta-analysis of 15 studies found a consistent inverse association between PFAS blood levels and several markers of cardiovascular health, including blood pressure control.
Prospective studies following pregnant women have found that higher gestational PFAS levels predict higher blood pressure during pregnancy and increased risk of preeclampsia — a particularly dangerous pregnancy-specific hypertension syndrome. These pregnancy data provide compelling evidence for PFAS cardiovascular effects given the clear temporality between exposure and outcome.
Antihypertensive Management in PFAS Contexts
Cardiologists and primary care physicians managing hypertension in PFAS-contaminated communities may encounter patients whose blood pressure is inadequately controlled despite appropriate medication. PFAS-induced RAAS activation may partially explain poor response to medications that target RAAS pathways (ACE inhibitors, ARBs) if PFAS continues to drive aldosterone excess.
Lifestyle interventions that address PFAS-related cardiovascular risk — reduced sodium intake, adequate potassium, aerobic exercise, and PFAS exposure reduction through water filtration — complement pharmacological management. Reducing ongoing PFAS intake removes a continuous cardiovascular stressor that medications must work against.